Peer-reviewed Publications

  • 2021

42. Teleki, A., and P. Artursson, “Drug delivery: Getting a grip with kirigami,” Nat. Mater. 20, 1043 (2021).

41. Hempel, N-J., P. Merkl, M.M. Knopp, R. Berthelsen, A. Teleki, A.K. Hansen, G.A. Sotiriou, and K. Löbmann, “The effect of the molecular weight of polyvinylpyrrolidone and the model drug on laser-induced in situ amorphization,” Molecules 26, 4035 (2021).

40. Hempel, N-J., P. Merkl, M.M. Knopp, R. Berthelsen, A. Teleki, G.A. Sotiriou, and K. Löbmann, “The influence of the drug-polymer solubility on laser-induced in situ drug amorphization using photothermal plasmonic nanoparticles,” Pharmaceutics 13, 917 (2021).

39. Hempel, N-J., P. Merkl, S. Asad, M.M. Knopp, R. Berthelsen, C.A.S. Bergström, A. Teleki, G.A. Sotiriou, and K. Löbmann, “Utilizing laser-activation of photothermal plasmonic nanoparticles to induce on-demand drug amorphization inside a tablet,” Mol. Pharm. 18, 2254 (2021).

38. Johannesson, J., J. Khan, M. Hubert, A. Teleki, and C.A.S. Bergström, “3D-printing of solid lipid tablets from emulsion gels,” Int. J. Pharm. 597, 120304 (2021).

37. Asad, S., C. Wegler, D. Ahl, C.A.S. Bergström, M. Phillipson, P. Artursson, and A. Teleki, “Proteomics-informed identification of luminal targets for in situ diagnosis of inflammatory bowel disease,” J. Pharm. Sci. 110, 239 (2021).

*       Selected by J. Pharm. Sci. editors for Virtual Issue: Most Original and Most Significant Scientific Findings.

  • 2020

36. Teleki, A., O. Nylander, and C.A.S. Bergström, “Intrinsic dissolution rate profiling of poorly water soluble compounds in biorelevant dissolution media,” Pharmaceutics, 12, 493 (2020).

  • 2019

35.  Bergström, C.A.S., K. Box, R. Holm, W. Matthews, M. McAllister, A. Mullertz, T. Rades, K.J. Schäfer, and A. Teleki, “Biorelevant intrinsic dissolution profiling in early drug development: fundamental, methodological and industrial aspects,” Eur. J. Pharm. Biopharm. 139, 101-114 (2019).

  • 2018

34.   Alison, L., A.F. Demirörs, E. Tervoort, A. Teleki, J. Vermant, and A.R. Studart, “Emulsions stabilized by chitosan-modified silica nanoparticles: pH control of structure-property relations,” Langmuir 34, 6147-6160 (2018).

  • 2017

33.   Plum, J., C.M. Madsen, A. Teleki, J. Bevernage, C. da Costa Mathews, E.M. Karlsson, S. Carlert, R. Holm, T. Müller, W. Matthews, A. Sayers, K. Ojala, K. Tsinsman, R. Lingamaneni, C.A.S. Bergstöm, T. Rades and A. Müllertz, “Investigation of the intra- and interlaboratory reproducibility of a small scale standardized supersaturation and precipitation method,” Mol. Pharm. 14, 4161-4169 (2017).

32.   Adler, C., A. Teleki and M. Kuentz, “Multifractal and mechanical analysis of amorphous solid dispersions,” Int. J. Pharm. 523, 91-101 (2017).

31.   Adler, C., A. Teleki and M. Kuentz, “Multifractal characterization of pharmaceutical hot-melt extrudates,” Pharm. Res. 34, 321-332 (2017).

  • 2016

30.   Alison, L., P.A. Rühs, E. Tervoort, A. Teleki, M. Zanini, L. Isa, and A.R. Studart, “Pickering and network stabilization of biocompatible emulsions using chitosan-modified silica nanoparticles,” Langmuir 32, 13446-13457 (2016).

29.   Mougin, K., A. Bruntz, D. Severin, and A. Teleki, “Morphological stability of microencapsulated vitamin formulations by AFM imaging,” Food Struct. 9, 1-12 (2016).

28.   Teleki, A., F.L. Haufe, A.M. Hirt, S.E. Pratsinis, and G.A. Sotiriou, “Highly scalable production of uniformly-coated superparamagnetic nanoparticles for triggered drug release from alginate hydrogels,” RSC Adv. 6, 21503-21510 (2016).

27.   Adler, C., M. Schoenenberger, A. Teleki and M. Kuentz, “Molecularly designed lipid microdomains for solid dispersions using a polymer/inorganic carrier matrix produced by hot-melt extrusion,” Int. J. Pharm. 499, 90-100 (2016).